|
| 35580849 | Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. | Clin Infect Dis | 2023 |
| 34704203 | Acute Hypoxemic Respiratory Failure with High Clinical Suspicion of COVID-19 Despite Negative PCR: a Case for Empiric Corticosteroids and Role of Serum Antibody in Diagnosis. | J Gen Intern Med | 2022 |
| 35675695 | Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. | Clin Infect Dis | 2022 |
| 35347854 | Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. | Influenza Other Respir Viruses | 2022 |
| 36264830 | Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35085218 | Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34932114 | Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. | J Infect Dis | 2022 |
| 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 |
| 33405338 | Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States. | Influenza Other Respir Viruses | 2021 |
| 34734975 | Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. | JAMA | 2021 |
| 34376307 | Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020. | Vaccine | 2021 |
| 34014274 | Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study. | Clin Infect Dis | 2021 |
| 34268515 | Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States. | medRxiv | 2021 |
| 33977301 | Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes. | Clin Infect Dis | 2021 |
| 32531129 | Bedside veno-venous ECMO cannulation: A pertinent strategy during the COVID-19 pandemic. | J Card Surg | 2020 |
| 33151918 | Telework Before Illness Onset Among Symptomatic Adults Aged â¿¥18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities - United States, July 2020. | MMWR Morb Mortal Wkly Rep | 2020 |
| 32915165 | Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults â¿¥18 Years in 11 Outpatient Health Care Facilities - United States, July 2020. | MMWR Morb Mortal Wkly Rep | 2020 |
| 26963357 | Ultrasound Diagnosis of Hemodynamic Compromise in a Patient with Hepatic Hydrothorax. | Ann Am Thorac Soc | 2016 |
| 27747109 | Case Report of a Fatal Antifreeze Ingestion with a Record High Level and Impressive Renal Crystal Deposition. | Case Rep Crit Care | 2016 |
| 9305464 | The effects of local application of ethanol in the n. accumbens on dopamine overflow and clearance. | Alcohol | 1997 |
| 8098187 | Ventral tegmental microinjections of quinpirole decrease ethanol and sucrose-reinforced responding. | Alcohol Clin Exp Res | 1993 |
| 8507386 | Specific decreases in ethanol- but not water-reinforced responding produced by the 5-HT3 antagonist ICS 205-930. | Alcohol | 1993 |